Ebola virus vaccine
Latest Information Update: 25 Mar 2017
At a glance
- Originator Nonindustrial sources
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Ebola virus infections
Most Recent Events
- 14 Dec 1998 New profile
- 14 Dec 1998 Preclinical development for Ebola virus infections in USA (Unknown route)